Get Ahead of 2026: How Pharma Leaders Are Navigating a Volatile Market
Get Ahead of 2026: How Pharma Leaders Are Navigating a Volatile Market
As the pharma landscape grows more complex, the year ahead will demand sharper positioning, stronger partnerships, and smarter communication.
At CPHI Frankfurt 2025, global pharma leaders discussed how they’re preparing for what’s next – from evolving supply chains to the changing role of AI and commercial strategy.
We’ve captured the most important takeaways and distilled them into a concise guide built for marketing and commercial decision-makers planning for 2026.
See What’s Shaping 2026
The pharma landscape is shifting fast – from supply resilience to AI adoption and new partnership models. Uncover the key forces redefining the industry so you can anticipate what’s coming, rather than react to it.
Turn Insight into Action
Volatility doesn’t have to mean uncertainty. Discover how leading pharma and biotech organisations are adapting their commercial and marketing strategies to stay credible, competitive, and connected to customer needs.
Built for Marketing Leaders
Designed for those shaping strategy, not just executing it. We help translate complex industry shifts into clear messaging, sharper positioning, and stronger market impact.
Download the Report
Learn how to cut through uncertainty – and stand out in 2026.
Fill in the form below to receive your free copy of “Standing Out in a Volatile Market: Key Insights from CPHI Frankfurt 2025”.
